Analyst upgrades typically lead to positive market sentiment in the short term, as they suggest a more favorable outlook for the company. The substantial increase in the price target from $1 to $4 indicates a significant change in the expected performance of Invivyd, which could lead to increased investor interest and a potential rise in the stock price.